The effect of emicizumab and bypassing agents in patients with hemophilia - An in vitro study.
Research and practice in thrombosis and haemostasis（2021）
摘要
We demonstrated a strong synergistic effect of emicizumab and aPCC and a similar but less pronounced effect of rFVIIa in people treated with emicizumab.
更多查看译文
关键词
activated prothrombin complex concentrate,blood coagulation tests,emicizumab,hemophilia A,rFVIIa
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要